No. CCP is not recommended as a screening test. Like RF, it is best used for patients whose clinical signs suggest RA or who have already been diagnosed with undifferentiated arthritis. CCP is best used in patients with suggestive features of RA, whose RF is negative. CCP is now also being used in specialist early arthritis clinics to identify patients with RA early.
This article was last reviewed on 31 May 2016. | This article was last modified on 31 May 2016.
The review date indicates when the article was last reviewed from beginning to end to ensure that it reflects the most current science. A review may not require any modifications to the article, so the two dates may not always agree.
The modified date indicates that one or more changes were made to the article. Such changes may or may not result from a full review of the article, so the two dates may not always agree.